Computational screening of natural compounds reveals glycyrrhisoflavone as a potential Hepatitis B X-interacting protein inhibitor
{{output}}
Background and objective: Hepatitis B virus (HBV) remains a major global health burden, affecting ∼296 million people worldwide. Chronic infection can progress to liver cirrhosis and hepatocellular carcinoma (HCC), partly due to... ...
